PY4-22322-49598

3 vaccinations 1 coded response 2 check-ins 0 free-text entries 0 call cases

Sex: Female
Age at first dose: 05-11
ZIP prefix: 045 / ME
Registered: 2022-09-23

Relationship: Child or adolescent in my care
Guardian: 33A-43729-59310
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-11
Dose 1 — Pfizer-BioNTech
2021-12-02
Dose 2 — Pfizer-BioNTech
2022-06-19
Dose 3 — Pfizer-BioNTech
2022-09-23
Registered in v-safe
2022-09-23
Health check-in — 3 months, dose 3, dependent
Feeling: Good

Adult check-in
2023-06-21
Survey response — 12 months, dose 3, dependent
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-11	Pfizer-BioNTech	No
2	2021-12-02	Pfizer-BioNTech	No
3	2022-06-19	Pfizer-BioNTech	No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release